147 related articles for article (PubMed ID: 8577939)
21. Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells.
Saïfia S; Chevrier AM; Bosshard A; Cuber JC; Chayvialle JA; Abello J
J Endocrinol; 1998 Apr; 157(1):33-41. PubMed ID: 9614355
[TBL] [Abstract][Full Text] [Related]
22. Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: possible existence of galanin receptor subtypes.
Hedlund PB; Finnman UB; Yanaihara N; Fuxe K
Brain Res; 1994 Jan; 634(1):163-7. PubMed ID: 7512426
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells.
Parker EM; Izzarelli DG; Nowak HP; Mahle CD; Iben LG; Wang J; Goldstein ME
Brain Res Mol Brain Res; 1995 Dec; 34(2):179-89. PubMed ID: 8750821
[TBL] [Abstract][Full Text] [Related]
24. Regulation of feeding by galnon.
Abramov U; Florén A; Echevarria DJ; Brewer A; Manuzon H; Robinson JK; Bartfai T; Vasar E; Langel U
Neuropeptides; 2004 Feb; 38(1):55-61. PubMed ID: 15003717
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor.
Wynick D; Smith DM; Ghatei M; Akinsanya K; Bhogal R; Purkiss P; Byfield P; Yanaihara N; Bloom SR
Proc Natl Acad Sci U S A; 1993 May; 90(9):4231-5. PubMed ID: 7683428
[TBL] [Abstract][Full Text] [Related]
26. Galanin-mediated control of pain: enhanced role after nerve injury.
Wiesenfeld-Hallin Z; Xu XJ; Langel U; Bedecs K; Hökfelt T; Bartfai T
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3334-7. PubMed ID: 1373497
[TBL] [Abstract][Full Text] [Related]
27. Galanin receptors in human basal forebrain differ from receptors in the hypothalamus: characterization using [125I]galanin (porcine) and [125I]galantide.
Deecher DC; Odusan OO; Mufson EJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):720-7. PubMed ID: 7473159
[TBL] [Abstract][Full Text] [Related]
28. Galanin receptors and their second messengers in the lumbar dorsal spinal cord.
Bedecs K; Langel U; Bartfai T; Wiesenfeld-Hallin Z
Acta Physiol Scand; 1992 Mar; 144(3):213-20. PubMed ID: 1374997
[TBL] [Abstract][Full Text] [Related]
29. Antisecretory effects of galanin and its putative antagonists M15, M35 and C7 in the rat stomach.
Kisfalvi I; Burghardt B; Bálint A; Zelles T; Vizi ES; Varga G
J Physiol Paris; 2000; 94(1):37-42. PubMed ID: 10761687
[TBL] [Abstract][Full Text] [Related]
30. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice.
Bhandari M; Kawamoto M; Thomas AC; Barreto SG; Schloithe AC; Carati CJ; Toouli J; Saccone GT
Pancreatology; 2010; 10(6):682-8. PubMed ID: 21242707
[TBL] [Abstract][Full Text] [Related]
31. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological and biochemical characterization of a recombinant human galanin GALR1 receptor: agonist character of chimeric galanin peptides.
Fitzgerald LW; Patterson JP; Conklin DS; Horlick R; Largent BL
J Pharmacol Exp Ther; 1998 Nov; 287(2):448-56. PubMed ID: 9808667
[TBL] [Abstract][Full Text] [Related]
33. A galanin-mastoparan chimeric peptide activates the Na+,K(+)-ATPase and reverses its inhibition by ouabain.
Langel U; Pooga M; Kairane C; Zilmer M; Bartfai T
Regul Pept; 1996 Apr; 62(1):47-52. PubMed ID: 8738882
[TBL] [Abstract][Full Text] [Related]
34. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells.
Fehmann HC; Habener JF
Endocrinology; 1992 May; 130(5):2890-6. PubMed ID: 1374016
[TBL] [Abstract][Full Text] [Related]
35. N-terminally elongated fragments of galanin(1-16) inhibit insulin secretion from isolated mouse islets.
Gregersen S; Langel U; Bartfai T; Ahrén B
Regul Pept; 1994 Aug; 53(1):31-7. PubMed ID: 7528437
[TBL] [Abstract][Full Text] [Related]
36. Spinal antinociception by morphine in rats is antagonised by galanin receptor antagonists.
Reimann W; Englberger W; Friderichs E; Selve N; Wilffert B
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):380-6. PubMed ID: 7531294
[TBL] [Abstract][Full Text] [Related]
37. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
Kahl U; Langel U; Bartfai T; Grundemar L
Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
[TBL] [Abstract][Full Text] [Related]
38. Structural requirements for galanin interaction with receptors from pancreatic beta cells and from brain tissue of the rat.
Lagny-Pourmir I; Lorinet AM; Yanaihara N; Laburthe M
Peptides; 1989; 10(4):757-61. PubMed ID: 2479930
[TBL] [Abstract][Full Text] [Related]
39. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
40. Galanin/alpha2-receptor interactions in central cardiovascular control.
Díaz-Cabiale Z; Narváez JA; Yanaihara N; González-Barón S; Fuxe K
Neuropharmacology; 2000 Jun; 39(8):1377-85. PubMed ID: 10818254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
